REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Mardentas (Lithuania)

Main Activities: Dental Equipment and Supplies Manufacturing | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: UAB Mardentas Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Mardentas is based in Lithuania, with the head office in Vilnius. The company operates in the Dental Equipment and Supplies Manufacturing industry. It was first established on February 15, 2002. It currently has a total number of 15 (2025) employees. From the latest financial highlights, UAB Mardentas reported a net sales revenue increase of 70.64% in 2024. UAB Mardentas’s net profit margin increased by 3.37% in 2024.

Headquarters
Ukmerges g. 364-1
Vilnius; Vilnius county; Postal Code: LT-14188

Contact Details: Purchase the UAB Mardentas report to view the information.

Basic Information
Total Employees:
Purchase the UAB Mardentas report to view the information.
Registered Capital:
Purchase the UAB Mardentas report to view the information.
Financial Auditors:
Purchase the UAB Mardentas report to view the information.
Incorporation Date:
February 15, 2002
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after UAB Mardentas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
70.64%
Total operating revenue
70.64%
Net Profit (Loss) for the Period
293.1%
Total Equity
14.52%
Net Profit Margin
3.37%
Return on Equity (ROE)
12.08%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?